Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kartoon Studios | TOON | Jan 30, 2025 | 0.53 | +3.91 |
Karyopharm Therapeutics | KPTI | Jan 30, 2025 | 0.66 | +0.56 |
Katapult | KPLT | Jan 30, 2025 | 9.15 | -0.97 |
Kayne Anderson BDC | KBDC | Jan 30, 2025 | 17.08 | +0.71 |
Kayne Anderson Energy Infrastructure Fund | KYN | Jan 30, 2025 | 13.40 | +1.29 |
Kazia Therapeutics ADR | KZIA | Jan 30, 2025 | 1.90 | +37.68 |
KB Financial Group ADR | KB | Jan 30, 2025 | 62.30 | +0.53 |
KB Home | KBH | Jan 30, 2025 | 68.76 | +2.44 |
KBR | KBR | Jan 30, 2025 | 55.81 | +2.29 |
KBW Bank Powershares | KBWB | Jan 30, 2025 | 71.49 | +0.82 |
KBW High Div Yield Financial Powershares | KBWD | Jan 30, 2025 | 15.09 | +1.55 |
KBW Prem Yield Equity REIT Powershares | KBWY | Jan 30, 2025 | 17.65 | +1.96 |
KBW Prop & Casuality Insur Powershares | KBWP | Jan 30, 2025 | 115.24 | +0.08 |
KBW Regional Banking Powershares | KBWR | Jan 30, 2025 | 63.11 | +0.56 |
KE Holdings | BEKE | Jan 30, 2025 | 18.32 | +5.53 |
Kearny Financial | KRNY | Jan 30, 2025 | 6.88 | -5.49 |
Keen Vision Acquisition | KVACU | Jan 30, 2025 | 11.11 | +0.09 |
Keen Vision Acquisition | KVAC | Jan 30, 2025 | 11.08 | 0.00 |
Kellanova | K | Jan 30, 2025 | 81.94 | +0.21 |
Kelly Services A | KELYA | Jan 30, 2025 | 14.19 | -0.56 |
Kelly Services B | KELYB | Jan 30, 2025 | 14.20 | +1.43 |
Kemper | KMPR | Jan 30, 2025 | 68.09 | +1.78 |
Kennametal | KMT | Jan 30, 2025 | 24.23 | +1.21 |
Kennedy-Wilson | KW | Jan 30, 2025 | 9.16 | +0.99 |
Kenon Holdings | KEN | Jan 30, 2025 | 30.85 | +0.64 |
Kentucky First Federal Bancorp | KFFB | Jan 30, 2025 | 3.39 | +5.61 |
Kenvue | KVUE | Jan 30, 2025 | 21.72 | +1.92 |
Keros Therapeutics | KROS | Jan 30, 2025 | 11.71 | +2.99 |
Keurig Dr Pepper | KDP | Jan 30, 2025 | 32.24 | +1.19 |
Kewaunee Scientific | KEQU | Jan 30, 2025 | 63.95 | +2.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.